Inst of the Americas

[Inst of the Americas @saludamericas]

"Merck chief Kenneth Frazier defends $8 billion R&D budget." FierceBiotech This is the only way to go in my opinion. http://t.co/zgHGegpJ

[Lee Tablewski @LeeTablewski]

@Xconomy: Ann Arbor-based NanoBio, Merck to Collaborate on Gates-Funded Respiratory Syncytial Virus (RSV) Vaccine: http://t.co/W5mkVdNs

[Larry Smarr @lsmarr]

Just posted my first article on the 10 yr quest to quantify my body. Quite a scientific detective story!
http://t.co/HVmcKfjo

[Inst of the Americas @saludamericas]

#saludperiodismo Una nota excelente de @elizaraujo en @DiarioTalCual sobre vacunas y los niños, 'Ganando la batalla' http://t.co/wxsyCkxW

[Inst of the Americas @saludamericas]

Vaccination key: RT @WHONEWS: Pneumonia is the leading cause of death in children worldwide http://t.co/KILqQcIf #WPD2011 via @WorldBankLAC

[Inst of the Americas @saludamericas]

Friend tells me cost 2 replace it is huge: RT @Discovery Most expensive part of our body is our bone marrow. #WhatsAmericaWorth @CuriosityTV

[Merck @Merck]

No woman should die giving life. Yet over the next 10 years, we know that more than 3 million mothers may be lost. #amillionmoms

[Inst of the Americas @saludamericas]

#saludperiodismo Informe y video de la Prof. de Harvard Felicia Knaul en español sobre cáncer: http://t.co/Ij729MCO http://t.co/yPf17aEa

[Inst of the Americas @saludamericas]

Informe y video de la Prof. de Harvard Felicia Knaul en español sobre cáncer: http://t.co/Ij729MCO
http://t.co/yPf17aEa

[Inst of the Americas @saludamericas]

RT: @clarincom Cáncer, el enemigo de los presidentes latinos: http://t.co/8lAkWiGk

[Inst of the Americas @saludamericas]

#saludperiodismo Cost 2 doing nothing v chronic disease globally $30 TRILLION (REV) by 2030. 1/4 people in Americas have chronic disease now

[Inst of the Americas @saludamericas]

#saludperiodsimo Innovation for emerging markets - MPDL live transmission in Mexico City

[Inst of the Americas @saludamericas]

#saludperiodismo Innovación para los mercados emergentes – Transmisión en vivo con MPDL Ciudad de México

[Inst of the Americas @saludamericas]

#saludperiodismo 2010 survey ranks Merck as best Biopharm partner - Reid Leonard MRL

[Inst of the Americas @saludamericas]

#saludperiodismo The changing model of industry –academic partnerships in drug discovery.. from handoff… to hands on - Reid Leonard MRL

[Inst of the Americas @saludamericas]

#saludperiodismo Singulair (montelukast) fue aprobado para el tratamiento del asma por la FDA en 1998 - Deborah Slipetz Merck Research Lab

[Inst of the Americas @saludamericas]

#saludperiodismo Slipetz 1998, 6 yrs after the 1st synthesis of the drug 18 yrs after Merck initiated its' program Singulair FDA approved

[Inst of the Americas @saludamericas]

#saludperiodismo - Singulair (montelukast) is approved for the treatment of asthma by the FDA in 1998 - Deborah Slipetz

[Inst of the Americas @saludamericas]

#saludperiodismo - Merck bcame world leader in leukotriene research as a provider of leukotrienes for the program&to academic investigators

[Inst of the Americas @saludamericas]

#saludperiodismo - Un caso de éxito del laboratorio al paciente – Deborah Slipetz, Líder, Sistema Respiratoria e Inmunología – MRL